Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease - Takeaways - MDSpire

Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease

  • By

  • Ana Belén Caminero

  • María Luisa Martínez Ginés

  • Montserrat Gómez Gutiérrez

  • Inmaculada García Castañón

  • May 28, 2026

  • 0 min

Share

  • 1

    Multiple sclerosis (MS) may begin years before clinical symptoms appear, indicating a biological continuum of disease progression.

  • 2

    The disease continuum includes genetic susceptibility, environmental factors, and early nonspecific symptoms preceding clinical manifestations.

  • 3

    Recent diagnostic criteria allow asymptomatic individuals with specific radiological findings to meet MS diagnostic criteria, reflecting underlying disease activity.

  • 4

    Emerging biomarkers and advanced neuroimaging techniques are crucial for detecting MS-related processes at earlier stages of the disease.

  • 5

    Understanding MS as a continuum can enhance risk stratification and the development of targeted monitoring strategies for high-risk individuals.

Original Source(s)

Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease

  • by Ana Belén Caminero, María Luisa Martínez Ginés, Montserrat Gómez Gutiérrez, Inmaculada García Castañón

  • May 28, 2026

Related Content

Listening to MS: AI-assisted speech analysis for diagnosis and fatigue prediction (COMMITMENT)

Loss of oligodendrocyte transcription factor 2 protein expression in metabolically stressed oligodendrocytes

Oxidized mannan-MOG35-55 conjugate as a basis for targeted immune modulation in multiple sclerosis